Solid Biosciences partners with Phlox for cardiac disease therapies
Pharmaceutical Technology
JANUARY 12, 2023
The collaboration will use the vector biology, manufacturing capabilities and the drug development experience of Solid Biosciences and Phlox Therapeutics’ knowledge in genetic cardiomyopathies and RNA therapies. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
Let's personalize your content